Market Overview:
The global genomics market reached a value of US$ 25.11 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.26 Billion by 2027, exhibiting a CAGR of 15.54% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Genomics is the study of the function, mapping, structure, evolution, and genomes (genes) of an individual. It relies on consumables, systems, software, and services for diagnostics, drug discovery, development of precision medicine, and agricultural research. It aids in providing diagnostic and predictive insights that help healthcare professionals in research and finalizing treatment options for diseases, such as Alzheimer's, diabetes, and cancer. As a result, it is utilized around the world in studying biological systems and solving complex genetic problems in hospitals, private clinics, diagnostic, and research centers.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Significant advancements in the genomic field, increasing prevalence of chronic and infectious disorders among the masses, and rising preferences for personalized medicines are major factors bolstering the market growth. It can also be attributed to the growing adoption of non-invasive cancer screening-based research. In addition, the expanding global population, changing climatic conditions, rising food security concerns, and spreading awareness about the harmful effects of chemical-based fertilizers are driving the need for genomics to improve crop yield. This, in confluence with the shifting consumer preferences for organic food products, is contributing to the market growth. Furthermore, expanding investments in research and development (R&D) of biotechnology, coupled with extensive improvements in medical infrastructure and diagnostic technologies, are creating a positive outlook for the market. Apart from this, the integration of genomics-based apps and tests to identify DNA alterations is offering lucrative growth opportunities to industry investors.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global genomics market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on component, application, technology, and end-user.
Breakup by Component:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Consumables and reagents hold the biggest market share as they aid in performing single-molecule and real-time (SMRT) sequencing.
Breakup by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
Functional genomics dominates the application segment as they help improve crop plants, human health, and livestock.
Breakup by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Sequencing exhibits a clear dominance in the market as it provides information on genetic variants that can lead to different diseases.
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Pharmaceutical and biotechnology companies hold the majority of the total market share as they help modify genes and provide a new platform for the high-throughput genetic analysis of forest trees.
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
North America holds the majority of the global genomics market share on account of increasing preferences for personalized medicines.
Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are 23andMe, Inc, Agilent Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Component, Application, Technology, End-User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Technology
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End-User
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2021
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2021
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2021
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2021
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Genomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players